Larry J. Jolivette

Novel Rho Kinase Inhibitors with Anti-inflammatory and Vasodilatory Activities

Chris P. Doe, Ross Bentley, David J. Behm et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 156 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

Krista Goodman, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 156 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure

Larry J. Jolivette, Keith W. Ward · Journal of Pharmaceutical Sciences · 2005 · 96 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases

Clark A. Sehon, Gren Z. Wang, Andrew Q. Viet et al. · Journal of Medicinal Chemistry · 2008 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity

Robert A. Stavenger, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17